Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana

被引:48
|
作者
Krings, Amrei [1 ,2 ,3 ,4 ]
Dunyo, Priscilla [5 ]
Pesic, Aleksandra [1 ,2 ,3 ,4 ]
Tetteh, Saviour [5 ]
Hansen, Benjamin [5 ]
Gedzah, Isaac [5 ]
Wormenor, Comfort M. [5 ]
Amuah, Joseph E. [6 ]
Behnke, Anna-Lisa [1 ,2 ,3 ,4 ]
Hofler, Daniela [7 ]
Pawlita, Michael [7 ]
Kaufmann, Andreas M. [1 ,2 ,3 ,4 ]
机构
[1] Charite Univ Med Berlin, Clin Gynecol, Lab Gynecol Tumor Immunol, Campus Benjamin Franklin, Berlin, Germany
[2] Free Univ Berlin, Campus Benjamin Franklin, Berlin, Germany
[3] Humboldt Univ, Campus Benjamin Franklin, Berlin, Germany
[4] Berlin Inst Hlth, Campus Benjamin Franklin, Berlin, Germany
[5] Catholic Hosp Battor, Battor, Volta Region, Ghana
[6] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada
[7] German Canc Res Ctr, Res Program Infect Inflammat & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany
来源
PLOS ONE | 2019年 / 14卷 / 06期
关键词
INFECTION; WOMEN; HPV; HIV;
D O I
10.1371/journal.pone.0218762
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction This population-based study aimed to fill the knowledge gap on Human Papillomavirus (HPV) prevalence and associated sociodemographic risk factors of the general population in the North Tongu District, Ghana. These results are needed to guide cervical cancer prevention efforts, as the leading type of female cancers. Methods A cross-sectional study including 2002 women in the North Tongu District, Ghana investigated HPV prevalence and associated sociodemographic risk factors. Women were recruited by geographical distribution through the local community-based health system and samples collected using a self-sampling device. For HPV genotyping BSGP5+/6+-PCR with Luminex-MPG readout was used. Multivariate logistic regression analyzed sociodemographic risk factors for HPV positivity. Results Of 2002 self-collected samples, 1943 were eligible, contained sufficient DNA and provided valid HPV genotyping results. Prevalence of single high risk HPV types was 32.3% and of multiple high risk types 9.7%. The five most common detected HPV types were HPV16 (7.4%; 95% CI: 6.3-8.7), HPV52 (7.2%; 95% CI: 6.1-8.5), HPV35 (4.8%; 95% CI: 3.9-5.8), HPV59 (4.7%; 95% CI: 3.8-5.8), HPV56 (3.9%; 95% CI: 3.1-4.8). Highest prevalence was observed among women aged 18-24 years, while age 25-54 years was inversely associated with high risk HPV positivity in multivariate analysis. Sociodemographic risk factors identified were i) having any sexual partner, ii) more partners increased the odds for high risk HPV positivity, iii) independently from this marital status, in particular not being married. Discussion & conclusion Most importantly, the high risk HPV prevalence detected from this study is higher than estimates reported for Western Africa. This needs be considered, when deciding on the cervical cancer screening algorithms introduced on a wider scale. Follow-up and triage, depending on the methods chosen, can easily overburden the health system. Self-sampling worked well and provided adequate samples for HPV-based screening. Women with increasing number of sexual partners and not being married were found to have higher odds of being high risk HPV positive, therefore could be a higher prioritized screening target group.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
    Dahlstrom, Lisen Arnheim
    Andersson, Kristin
    Luostarinen, Tapio
    Thoresen, Steinar
    Ogmundsdottir, Helga
    Tryggvadottir, Laufey
    Wiklund, Fredrik
    Skare, Gry B.
    Eklund, Carina
    Sjolin, Kia
    Jellum, Egil
    Koskela, Pentti
    Wadell, Goran
    Lehtinen, Matti
    Dillner, Joakim
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (12) : 2541 - 2550
  • [42] Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania
    Suteu, Ofelia
    Blaga, Mihaiela L.
    Nygard, Mari
    Leinonen, Maarit K.
    Nicula, Florian
    Pais, Rodica
    Coza, Daniela
    Cadariu, Patriciu A.
    Melnic, Adriana
    Andreassen, Trude
    Hashim, Dana
    Weiderpass, Elisabete
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (02) : 141 - 148
  • [43] Prevalence and Risk Factors for High-Risk Human Papillomavirus Infection and Cervical Disorders: Baseline Findings From an Human Papillomavirus Cohort Study
    Saldana-Rodriguez, Paula
    Bahena-Roman, Margarita
    Delgado-Romero, Karina
    Madrid-Marina, Vicente
    Torres-Poveda, Kirvis
    CANCER CONTROL, 2023, 30
  • [44] Human Papillomavirus Type-Specific Prevalence in the Cervical Cancer Screening Population of Czech Women
    Tachezy, Ruth
    Smahelova, Jana
    Kaspirkova, Jana
    Salakova, Martina
    PLOS ONE, 2013, 8 (11):
  • [45] Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer
    Berza, Natalija
    Zodzika, Jana
    Kivite-Urtane, Anda
    Baltzer, Nicholas
    Curkste, Alise
    Pole, Ilva
    Nygard, Mari
    Parna, Kersti
    Stankunas, Mindaugas
    Tisler, Anna
    Uuskula, Anneli
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34 (04):
  • [46] Prevalence of co-infection with human papillomavirus and Chlamydia trachomatis and risk factors associated with cervical cancer in Congolese women
    Mouabata, Dorine Florence Luthera Ngombe
    Boumba, Anicet Luc Magloire
    Massengo, Norvi Rigobert Bienvenu
    Pouki, Freddy Saturnin
    Moukassa, Donatien
    Ennaji, Moulay Mustapha
    MICROBES AND INFECTION, 2024, 26 (03)
  • [47] Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia
    Elsa Tesfaye
    Birhanu Kumbi
    Belayihun Mandefro
    Yadesa Hemba
    Krushna Kant Prajapati
    Suresh Chandra Singh
    Vijay Upadhye
    Sunil Tulshiram Hajare
    Scientific Reports, 14
  • [48] Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia
    Tesfaye, Elsa
    Kumbi, Birhanu
    Mandefro, Belayihun
    Hemba, Yadesa
    Prajapati, Krushna Kant
    Singh, Suresh Chandra
    Upadhye, Vijay
    Hajare, Sunil Tulshiram
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [49] High-risk human papillomavirus test a good option for cervical cancer screening
    Printz, Carrie
    CANCER, 2018, 124 (24) : 4591 - 4591
  • [50] Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
    Stuebs, Frederik A.
    Koch, Martin C.
    Dietl, Anna K.
    Adler, Werner
    Geppert, Carol
    Hartmann, Arndt
    Knoell, Antje
    Beckmann, Matthias W.
    Mehlhorn, Grit
    Schulmeyer, Carla E.
    Gass, Paul
    DIAGNOSTICS, 2022, 12 (07)